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Abstract  
AIM: To evaluate intrarenal resistivity index (RI) and different biomarkers of diabetic nephropathy (DN) with 
clinical signs of DN and its progression over time as early detection of DN. 
PATIENTS AND METHODS: This longitudinal study included 48 type 1 diabetic patients who were studied at 
baseline and after three years. A blood sample was taken for assessment of glycosylated haemoglobin (HbA1), 
lipid profile and a urine sample was taken for assessment of albumin/creatinine ratio, Neutrophil gelatinase-
associated lipocalin (NGAL), liver-type fatty acid binding protein (L-FABP) and kidney injury molecule-1 (Kim-1) at 
baseline and after three years. Forty diabetic patients did renal Doppler at baseline & after three years. 
 
RESULTS: HbA1, waist/hip ratio, albumin/creatinine ratio, lipid profile, NGAL, KIM-1, L-FABP and resistivity index 
(RI) were significantly increased in follow-up. Twenty patients (41.7%) showed progression to albuminuria. RI 
showed a significant increase in follow-up study. ROC curve showed that RI and NGAL had the highest sensitivity 
(100%), followed by L-FABP (90%) and lastly KIM-1 (63.6%) in the prediction of DN. 
 
CONCLUSION: High RI, NGAL, KIM-1 & L-FABP can be considered as early markers of diabetic nephropathy in 
type 1 diabetics and are associated with its progression over time, independent of albuminuria. 
 
 
 
 
 
 
Introduction 
 
As a result of rising prevalence of type 1 
diabetes, its complications including diabetic 
nephropathy (DN) affect more patients, but these 
complications rarely present clinically in childhood and 
adolescence. However, early functional and structural 
abnormalities may be present a few years after the 
onset of the disease [1-4]. Consequently, early 
sensitive markers that reflect the stage and course of 
diabetic nephropathy are needed to prevent 
progression to end-stage renal disease and dialysis 
as 1 of 3 patients with diabetic nephropathy develops 
end-stage renal disease (ESRD) [5] and the 
cumulative incidence of ESRD is 8%, 30 years after 
onset of type 1 diabetes (T1D) [6]. 
 Our previous study [4] and many other recent 
studies [7-9] have shown that intrarenal resistivity 
index (RI), Neutrophil gelatinase-associated lipocalin 
(NGAL), liver-type fatty acid binding protein (L-FABP) 
and kidney injury molecule-1 (Kim-1) are promising 
early highly sensitive and highly specific (especially 
NGAL) markers for diagnosis of DN even in pre 
albuminuric stage because it has been shown that 
renal tubular damage can precede microalbuminuria 
and consequently allow early detection of DN, offering 
a good chance for delaying or even preventing 
progression to end-stage renal disease. However, the 
role of these early markers in the progression of 
diabetic nephropathy needs further evaluation.
 
 Previous studies including our previous study 
[4] have shown that urinary levels of the tubular 
markers NGAL and KIM-1 [9, 10] and urinary L-FABP 
[11, 12] are increased in type 1 diabetic (T1D) 
patients, even before they develop signs of glomerular 
damage, i.e. micro- or macroalbuminuria. Also, u-
NGAL is increased in type I diabetic patients 
compared to healthy controls, and increases with 
increasing levels of albuminuria [4, 10], so NGAL 
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represents an early biomarker of ‘normoalbuminuric’’ 
DN with a good sensitivity and specificity.  
In the current work, we are aiming to explore 
and evaluate whether increased intrarenal resistivity 
index (RI) and increased different biomarkers of 
diabetic nephropathy (DN) are associated with clinical 
signs of DN and its progression over time i.e. 
predictors of progression thus representing important 
non-invasive tests to make precocious diagnosis of 
‘‘normoalbuminuric'' DN. 
 
 
Patients and Methods 
 
Patients 
This longitudinal study included 48 type 1 
diabetic patients among those attending to the 
endocrine clinic, National Research Centre, who were 
studied at baseline and after three years.
 
Inclusion criteria at baseline: Patients with 
duration of disease > 5 years, patients age > 14 and < 
19 yrs old. 
Exclusion criteria were as follows: Patients 
during acute diabetic complications e.g. diabetic 
ketoacidosis (DKA) or hypoglycemia, Patients 
suffering from cardiac diseases e.g. congenital, 
rheumatic heart, left ventricular dysfunction, Patients 
receiving drugs for cardiovascular disease. 
 
Study design and protocol 
It is a longitudinal study done after obtaining 
approval from the ethical committee of the National 
Research Centre, Cairo, Egypt. The registration 
number is 14058. It conforms to the provisions of the 
Declaration of Helsinki (as revised in Edinburgh 
2000). Written informed consent was obtained from all 
patients, their parents and controls after a full 
discussion about the aim of the study. This study is a 
part of a project done at the National Research Centre 
in collaboration with Cairo University for evaluation of 
cardiac, vascular and endothelial function in 
adolescent type 1 diabetic patients. 
 
All the studied patients were subjected to 
history taking including the age of patients, sex, the 
age of onset of diabetes, duration of diabetes, type 
and dose of insulin therapy, family history of diabetes. 
We asked about the presence of any symptoms of 
cardiac, renal, neurological affection or presence of 
any autonomic dysfunction. We also asked about the 
history of taking drugs other than insulin.
 
Patients were subjected, at baseline and after 
three years, for general, cardiac, chest and 
neurological examination.
 
Blood pressure was measured three times for 
patients after 5-minute rest in the sitting position on 
both upper limbs with the use of automatic manometer 
(Omron M4 Plus, Omron Health care Europe, Hoof 
drop, and Holland). The mean value of the second 
and the third measurement was calculated. The 
measurements taken on the dominant limb were 
analysed. 
 
 All patients underwent the following tests at baseline 
and after three years:
 
For cholesterol measurements, venous blood 
was sampled after 12 hr fast. Serum total cholesterol 
was determined by a commercial kit (Boehringer-
Mannheim, Germany). High-density lipoprotein (HDL) 
cholesterol was separated from the serum by 
precipitation of the other lipoproteins with a 
heparin/manganese procedure [13]. Low-density 
lipoprotein (LDL) cholesterol was calculated using the 
Friedewald equation. The concentration of 
triglycerides was measured in a TechnoCon 
AutoAnalyzer II (TechnoCon Instruments, Tarrytown, 
New York).  
Glycosylated haemoglobin (HbA1) was 
determined spectrophotometrically using commercially 
kit supplied by Stanbio, USA according to the method 
described by Trivelli et al. [14]. Glycosylated 
haemoglobin (HbA1) was done every three months, 
and the mean value was calculated from the four 
readings of the last year, at baseline and after three 
years. 
Screening for microalbuminuria was assessed 
in fresh morning urine samples by measuring 
albumin/creatinine ratio by enzyme-linked 
immunosorbent assay (ELISA) kit provided by 
(Orgentec Diagnostika, Gmbh, Mainz, Germany) [15]. 
 Freshly voided urine specimens were collected early 
in the morning from patients and controls. Urine 
samples were placed at 4°C and transported directly 
to the laboratory where they were centrifuged to 
remove sediment and frozen in aliquots at −80°C for 
further analysis. Urinary biomarkers levels were 
standardised to urine creatinine measured in the 
same spot urine and expressed related to mg Cr. 
 
 Urinary NGAL and KIM-1 were assessed by enzyme-
linked immunosorbent assay (ELISA) using a kit from 
Quantikine; R & D Systems, Minneapolis; USA. L-
FABP was measured with a commercially available 
ELISA kit according to manufacturer's protocol 
(Biovendor Laboratory Medicine, Brno, Czech 
Republic). The inter- and intraassay coefficients of 
variation for NGAL, KIM-1, and L-FABP were <10%. 
The measurements were made in duplicate and a 
blinded fashion.
 
 Only 40 patients were subjected to renal colour 
duplex ultrasound scans at baseline & after three 
years, using 3-6 MHz convex array transducer 
(Toshiba, Xario ultrasound machine). Patients were 
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scanned in the supine position. The transducer was 
placed in longitudinal position just to the Lt. of the 
midline, recording colour flow & Doppler spectrum 
from the abdominal aorta where peak systolic velocity 
of the abdominal aorta was recorded. Then, the 
transducer was placed in transverse position just 
distal to the origin of superior mesenteric artery, to 
achieve transverse view of the aorta at the origins of 
both renal arteries where peak systolic velocity of both 
renal arteries was recorded, and renal artery stenosis 
was ruled out in all patients by tracing and examining 
different segments of both renal arteries form origin to 
renal hilum. Then, resistivity indices were recorded in 
the segmental, interlobar and arcuate arteries, on both 
sides.
 
 
Statistical Analysis 
T-test for dependent and independent 
variables was used for analysis of data. McNemar test 
was also used. ROC curve was used for detection of 
cut-off value for detection of best sensitivity and 
specificity of NGAL, KIM-1, L-FABP and RI.
 
 
 
Results 
 
This longitudinal study included 48 type 1 
diabetic patients who were studied at baseline and 
after three years. 
 
Table 1: Descriptive statistics of basal demographic, 
anthropometric and laboratory data of diabetic patients  
Basal Minimal Maximum Mean SD 
Age (yrs) 13.50 19.30 16.17 1.58 
Duration of disease (yrs) 5.00 16.30 9.17 2.87 
Insulin (U/kg) 0.77 2.03 1.38 0.32 
Systolic blood pressure (mmHg) 100.00 160.00 119 13.64 
Diastolic blood pressure (mmHg) 60.00 100.00 76.95 10.66 
Waist circumference (cm) 69.00 103.50 82.76 9.12 
Hip circumference (cm) 78.50 106.00 91.70 7.21 
Waist/hip ratio 0.78 1.06 0.87 0.09 
Waist/height ratio
 0.42 0.65 0.51 0.06 
BMI (SDS) -1.10 2.70 1.24 0.89 
BMI (Kg/m^2) 18.20 31.40 24.47 3.61 
HbA1 (%) 5.90 15.00 8.98 1.66 
Albumin/creatinine ratio (µg/g) 7.61 384.20 26.84 45.94 
Cholesterol (mg/dl) 100.00 431.00 188.7 70.83 
Triglycerides (mg/dl)
 35.00 289.00 96.61 58.22 
HDL-c (mg/dl) 21.00 136.00 51.68 22.99 
LDL-c (mg/dl) 22.00 210.00 111.86 33.36 
OxLDL (mg/dl) 8.70 37.10 18.35 7.16 
Urinary NGAL (g/ml) 97.00 378.00 178.50 62.73 
Urinary Kim-1 (ng/g creatinine) 21.00 216.00 70.69 51.37 
Urinary L-FABP (µg/g 
creatinine)
 
1.50 58.60 15.41 26.14 
Resistivity Index
 0.55 0.74 0.60 0.04 
BMI, Body mass index; HbA1, glycosylated  haemoglobin; HDL-c, high-density lipoprotein 
cholesterol; LDL-c, low-density lipoprotein cholesterol; OxLDL, oxidised low-density 
lipoprotein;  NGAL, neutrophil gelatinase associated lipocalin; L-FABP, liver-type fatty acid 
binding protein; Kim-1, urine levels of kidney injury molecule-1.
 
 
The studied group comprised of 26 females 
and 22 males, with a baseline mean age of 16.17 ± 
1.58 years and duration of diabetes of 9.17 ± 2.87 
years and a follow-up mean age of 19.46 ±1.52 years 
and duration of diabetes of 12 ± 3.59 years. All 
diabetic patients were on intensive insulin therapy 
regimen. 
 
Table 2: Descriptive statistics of follow-up demographic, 
anthropometric and laboratory data  of diabetic patients  
Follow-up
 Minimal Maximum Mean SD 
Age (yrs) 17.00 23.00 19.46 1.52 
Duration of disease (yrs) 8.00 20.50 12.00 3.59 
Onset of disease (yrs) 1.50 17.00 7.47 3.24 
Systolic blood pressure (mmHg) 100.00 150.00 120 13.0 
Diastolic blood pressure (mmHg) 50.00 100.00 80.49 8.86 
Waist circumference (cm) 50.00 103.00 81.88 10.67 
Hip circumference (cm) 78.00 113.00 94.56 8.59 
HbA1 (%) 6.00 15.00 9.51 1.84 
Albumin/ creatinine ratio (µg/g) 11.00 400.00 87.60 103.0 
Cholesterol (mg/dl) 84.00 400.00 208.8 74.60 
Triglycerides (mg/dl)
 36.00 288.00 116.83 58.46 
HDL-c (mg/dl) 30.00 130.00 50.91 19.66 
LDL-c (mg/dl) 38.00 231.00 117.56 39.90 
OxLDL (mg/dl) 1.30 7.80 43.93 15.13 
Urinary NGAL (g/ml) 25.70 410.70 212.41 72.81 
Urinary Kim-1 (ng/g creatinine) 0.10 46.30 145.08 90.24 
Urinary L-FABP (µg/g creatinine) 2.00 120.00 20.19 28.96 
Resistivity Index
 0.60 0.74 0.66 0.03 
BMI, Body mass index; HbA1, glycosylated haemoglobin; HDL-c, high-density lipoprotein 
cholesterol; LDL-c, low-density lipoprotein cholesterol; OxLDL, oxidised low-density 
lipoprotein;  NGAL, neutrophil gelatinase-associated lipocalin; L-FABP, liver-type fatty acid 
binding protein; Kim-1, urine levels of kidney injury molecule-1. 
 
 
Only 40 diabetic patients did renal Doppler, 
while all patients did all laboratory investigation, at 
baseline and after three years. Descriptive statistics of 
demographic, anthropometric and laboratory data 
(basal and after three years) of diabetic patients were 
shown in Tables 1 and 2. Comparison between 
demographic, laboratory data and resistivity index of 
patients at baseline and after three years, were shown 
in Table 3.  
Table 3: Comparison between demographic, laboratory data 
and renal Doppler at the beginning and after three years follow-
up in type 1 diabetic patients (n = 48)
 
Variables 
Basal Follow-up
 
P-value 
Mean SD Mean SD 
Demographic  data:      
Systolic blood pressure (mmHg) 119 13.64 120 13.0 0.7 
Diastolic blood pressure (mmHg) 76.95 10.66 80.49 8.86 0.04 
BMI (kg/m^2) 24.47 3.61 24.67 3.15 0.7 
Waist/hip 0.87 0.09 0.90 0.07 0.02 
Waist/height 0.51 0.06 0.50 0.07 0.3 
Laboratory data:      
HbA1 (%) 8.98 1.66 9.51 1.84 0.003 
Albumin/ creatinine ratio (µg/g) 26.84 45.94 87.60 103.0 0.007 
Cholesterol (mg/dl) 188.7 70.83 208.8 74.60 0.002 
Triglyceride (mg/dl) 96.61 58.22 116.83 58.46 0.0001 
HDL-c (mg/dl) 51.68 22.99 50.91 19.66 0.8 
LDL-c (mg/dl) 111.86 33.36 117.56 39.90 0.02 
OxLDL(mg/dl) 18.35 7.16 43.93 15.13 0.0001 
Urinary NGAL (g/ml) 178.50 62.73 212.41 72.81 0.002 
Urinary Kim-1 (ng/g creatinine) 70.69 51.37 145.08 90.24 0.0001 
Urinary L-FABP (µg/g creatinine) 15.41 26.14 20.19 28.96 0.01 
Resistivity Index
 0.60 0.04 0.66 0.03 0.0001 
 
t-Test for independent variables; BMI, Body mass index; HbA1, glycosylated haemoglobin; 
HDL-c, high-density lipoprotein cholesterol; LDL-c, low-density lipoprotein cholesterol; 
OxLDL, Oxidised low-density lipoprotein;  NGAL, neutrophil gelatinase-associated 
lipocalin; L-FABP, liver-type fatty acid binding protein; Kim-1, urine levels of kidney injury 
molecule-1. The bold values in the table indicate significance.
 
 
HbA1, diastolic blood pressure, waist/hip 
ratio, albumin/ creatinine ratio, lipid profile, NGAL, 
KIM-1, L-FABP and RI were significantly increased in 
follow-up. Twenty patients (41.7%) showed 
progression to albuminuria while the remaining 28 
patients (58.3%) showed stationary or regressed 
albuminuria. The progressed group showed 
significantly high basal NGAL (p = 0.01), basal KIM-1 
(p = 0.01) & basal L-FABP (p = 0.04) with high basal 
RI but not statistically significant (p = 0.09) (Table 4).  
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Table 4: Comparison between basal NEGAL, KIM-1, L-FABP 
and resistivity index about microalbuminuria
 
Variables 
Microalbuminuria 
 
Stationary or regressed 
N = 28 
Progressed 
N = 20 P-value 
Mean SD Mean SD 
Urinary NGAL (g/ml) 155.20 47.85 199.04 69.14 0.01 
Urinary Kim-1 (ng/g creatinine) 49.25 26.38 83.21 53.72 0.01 
Urinary L-FABP (µg/g creatinine) 6.26 3.65 10.70 10.58 0.04 
Resistivity Index
 0.59 0.02 0.61 0.04 0.09 
t-Test for independent variables. NGAL, neutrophil gelatinase-associated lipocalin; L-
FABP, liver-type fatty acid binding protein; Kim-1, urine levels of kidney injury molecule-1. 
The bold values in the table indicate significance. 
 
Basal NGAL, KIM-1, L-FABP & R.I. were high 
in diabetic patients who progressed to albuminuria 
and noted in 80%, 55%, 45% & 30% respectively at 
baseline (Table 5).  
Table  5: Frequency distribution of  basal level of  NEGAL, KIM-
1, L-FAB and resistivity index  in diabetic patients with  
progressive albuminuria (N =20) 
Basal N % 
NGAL:   
Normal 4 20 
Abnormal 16 80 
KIM-1:   
Normal 9 45 
Abnormal 11 55 
L-FABP   
Normal 11 55 
Abnormal 9 45 
Resistivity Index:
   
Normal 14 70 
Abnormal 6 30 
NGAL, neutrophil gelatinase-associated lipocalin; L-FABP, liver-type fatty acid binding 
protein; Kim-1, urine levels of kidney injury molecule-1.
 
 
RI showed a significant increase in follow-up 
study where R.I. was abnormally increased in 9 
patients (22.5%) at baseline while increased in 33 
patients (82.5%) in the follow-up study after three 
years (P value=0.0001) (Table 6).  
Table 6: Comparison between resistivity index at the beginning 
and after three years follow-up (N =40) 
Variables Follow-up
 P-value 
Normal Abnormal 
Basal N % N %  
Normal (N = 31) 5 16.1 26 83.9 0.0001 
Abnormal (N = 9) 2 22.2 7 77.8  
McNamara test was used for analysis of data. What abnormal resistivity index after three 
years follow-up was significantly higher in diabetic patients. The bold value in the table 
indicates significance. 
 
ROC curve showed that RI and NGAL had the 
highest sensitivity (100%), followed by L-FABP (90%) 
and lastly was KIM-1 (63.6%) in the prediction of DN 
(Table 7). 
Table 7:  ROC curve of basal resistivity index,  NEGAL, KIM-1 
and  L-FAB of  diabetic of patients 
Variables RI NGAL KIM-1 L-FABP 
Cut off 0.575 >94 >45 > 10.3 
Area under the 
curve  
0.587 0.645 0.606 0.941 
SE 0.115 0.096 0.097 0.050 
95% C.I. 0.434 – 0.728 0.527 – 0.752 0.487 – 0.716 0.862 – 0.982 
Sensitivity 100 100 63.6 90.0 
Specificity 28.2 32.3 61.5 87.7 
PPV 1.39 1.48 1.65 6.65 
NPV 0 0 0.59 0.21 
PPV = Positive predictive value; NPV = Negative predictive value; C.I.  = Confidence 
interval; NGAL = neutrophil gelatinase associated lipocalin; L-FABP = liver-type fatty acid 
binding protein; Kim-1= urine levels of kidney injury molecule-1; RI = resistivity index; RT = 
resistivity index. 
Discussion 
 
 Early management of DN is very important to prevent 
progression to end-stage renal disease and dialysis, 
and the current commonly used parameter to 
diagnose DN is microalbuminuria which is a non-
optimal biomarker with low sensitivity and specificity, 
so there is a necessity to explore and evaluate 
whether increased intrarenal resistivity index (RI) and 
increased different biomarkers, like NGAL, KIM-1 and 
L-FABP are associated with clinical signs of DN and 
its progression over time i.e. predictors of 
progression.
 
 In our previous cross-sectional study [4], we 
have found that R.I., NGAL, L-FABP & KIM-1 are 
increased in type 1 diabetic patients compared to 
normal controls, and increase with increasing levels of 
albuminuria. Being a cross-sectional study, it does not 
describe the time perspective or causality, so these 
findings inspired us to look at these markers in a 
longitudinal study. 
 The current longitudinal study revealed significantly 
increased HbA1, diastolic blood pressure, waist/hip 
ratio, albumin/ creatinine ratio, lipid profile, NGAL, 
KIM-1, L-FABP and RI in the follow up after three 
years and twenty patients (41.7%) progressed to 
albuminuria while the remaining 28 patients (58.3%) 
showed stationary or regressed albuminuria. 
 
 The progressed group showed increased 
basal RI but not statistically significant (p = 0.09) as 
R.I. was increased in diabetic patients who 
progressed to albuminuria in 30% at baseline. RI 
showed a significant increase in follow-up a study 
where R.I. was abnormally increased in 9 patients 
(22.5%) at baseline while increased in 33 patients 
(82.5%) in the follow-up study after three years (P 
value = 0.0001). ROC curve revealed that RI showed 
a sensitivity of 100% in the prediction of DN. Our 
results are in agreement with the results seen in type 
1 diabetic patients of many previous studies that 
demonstrated increased resistivity indices early in the 
course of DN in the pre albuminuric stage [4, 16, 17]. 
Also, Masulli et al. [18] reported similar results but in 
type 2 diabetic patients as they found that high RI is 
associated with features of DN and its progression 
over time, independent of albuminuria. 
 In our study, the progressed group showed 
significantly high basal NGAL (p = 0.01), basal KIM-1 
(p = 0.01) & basal L-FABP (p = 0.04) where basal 
NGAL, KIM-1, & L-FABP were high in diabetic 
patients who progressed to albuminuria in 80%, 55% 
& 45%, respectively at baseline. NGAL, KIM-1 & L-
FABP showed significant increase in follow-up (P 
values = 0.002, 0.0001, and 0.01 respectively). ROC 
curve revealed that NGAL showed a sensitivity of 
100%, followed by L-FABP (90%) and lastly is KIM-1 
(63.6%) in the prediction of DN. Our results are 
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comparable with the previous studies on diabetic 
patients that found that the levels of NGAL, KIM-1 and 
L-FABP are increased in type 1 diabetic patients, 
even before they develop albuminuria and also found 
that their levels were increased with increasing levels 
of albuminuria [4, 9-12, 19]. We found that NGAL has 
the highest sensitivity (100%) in the prediction of DN 
in line with the previous study that found a positive 
correlation between uNGAL and albuminuria and 
concluded that NGAL measurement could be useful 
for the evaluation of early renal involvement in the 
course of diabetes [19]. 
 We conclude that resistivity indices and renal tubular 
biomarkers are increased before the appearance of 
pathological albuminuria, which is the earlier 
measurable sign of renal diabetic involvement, 
supporting the hypothesis of a tubular phase of DN 
preceding the glomerular phase and consequently, 
the increase in R.I. and renal tubular biomarkers' 
values could express the degree of subclinical tubular 
impairment preceding the classic glomerular signs. 
R.I. and these new tubular biomarkers offer an 
advantage to urinary albumin on early detection of 
DN. We recommend these non-invasive tests for 
monitoring type 1 diabetic patients to predict those at 
risk of diabetic nephropathy as this longitudinal study 
design allow us to conclude that RI and tubular 
biomarkers precede the development of diabetic 
nephropathy and microalbuminuria.
 
 
 
References 
1. Chiarelli F, Cipollone F, Romano F, Tumini S, Costantini F, et al. 
Increased circulating nitric oxide in young patients with type 1 
diabetes and persistent microalbuminuria: relation to glomerular 
hyperfiltration. Diabetes. 2000;49:1258–63. 
https://doi.org/10.2337/diabetes.49.7.1258 PMid:10909986  
2. Savino A, Pelliccia P, Schiavone C, Primavera A, Tumini S, et al. 
Serum and urinary nitrites and nitrates and Doppler sonography in 
children with diabetes. Diabetes Care. 2006;29:2676–81. 
https://doi.org/10.2337/dc06-0346 PMid:17130204  
 
3. Komers R, Anderson S. Paradoxes of nitric oxide in the diabetic 
kidney. Am J Physiol Renal Physiol. 2003;284:F1121–37. 
https://doi.org/10.1152/ajprenal.00265.2002 PMid:12736164  
 
4. Abd El Dayem S, El Bohy A and El Shehaby A. Value of the 
intrarenal arterial resistivity indices and different renal biomarkers 
for early identification of diabetic nephropathy in type 1 diabetic 
patients. J Pediatr Endocrinol Metab. 2015; aop. 
 
5. Parving HH, Jacobsen P, Rossing K, Smidt UM, Hommel E, et 
al. Benefits of long term antihypertensive treatment on prognosis in 
diabetic nephropathy. Kidney Int. 1996; 49: 1778–82. 
https://doi.org/10.1038/ki.1996.266 PMid:8743496  
 
6. Finne P, Reunanen A, Stenman S, Groop PH, Gronhagen-Riska 
C: Incidence of end-stage renal disease in patients with type 1 
diabetes. JAMA. 2005; 294: 1782–87. 
 
https://doi.org/10.1001/jama.294.14.1782 PMid:16219881  
7. Pfleiderer S, Zimmerhackl LB, Kinne R, Manz F, Schuler G, et 
al. Renal proximal and distal tubular function is attenuated in 
diabetes mellitus type 1 as determined by the renal excretion of 
alpha 1-microglobulin and Tamm-Horsfall protein. Clin Investig. 
1993;71:972–7. https://doi.org/10.1007/BF00180026 
PMid:7510155  
 
8. Yaqoob M, McClelland P, Patrick AW, Stevenson A, Mason H, et 
al. Evidence of oxidant injury and tubular damage in early diabetic 
nephropathy. QJM. 1994;87:601–7. PMid:7987655  
 
9. Lacquaniti A, Donato V, Pintaudi B, Vieste GD, Chirico V, et al. 
''Normoalbuminuric'' diabetic nephropathy: tubular damage and 
NGAL. Acta Diabetol. 2013;50:935–42. 
https://doi.org/10.1007/s00592-013-0485-7 PMid:23754672  
 
10. Nielsen SE, Schjoedt KJ, Astrup AS, Tarnow L, Lajer M, et al. 
Neutrophil gelatinase-associated lipocalin (NGAL) and kidney 
injury molecule-1 (KIM-1) in patients with diabetic nephropathy: a 
cross-sectional study and the effects of lisinopril. Diabet Med. 
2010;27:1144–50. https://doi.org/10.1111/j.1464-
5491.2010.03083.x PMid:20854382  
 
11. Nielsen SE, Sugaya T, Hovind P, Baba T, Parving HH, et al. 
Urinary liver-type fatty acid-binding protein predicts progression to 
nephropathy in type 1 diabetic patients. Diabetes Care. 
2010;33:1320–4. https://doi.org/10.2337/dc09-2242 
PMid:20185732 PMCid:PMC2875447 
 
12. Nielsen SE, Sugaya T, Tarnow L, Lajer M, Schjoedt KJ, et al. 
Tubular and glomerular injury in diabetes and the impact of ACE 
inhibition. Diabetes Care. 2009;32:1684–8. 
https://doi.org/10.2337/dc09-0429 PMid:19502542 
PMCid:PMC2732168 
 
13. Marques-Vidal P, Ferrario M, Kuulasmaa K, Grafnetter D, 
Moltchanov V, for the WHO MONICA Project. Quality assessment 
of data on HDL cholesterol in the WHO MONICA Project (1999). 
Available from: URL:http://www.thl.fi/publications/monica/ 
hdl/hdlqa.htm, URN:NBN:fi-fe19991137. 
 
14. Trivelli LA, Ranney HM, Lai HT. Hemoglobin components in 
patients with diabetes mellitus. N Engl J Med. 1971;284:353–7. 
https://doi.org/10.1056/NEJM197102182840703 PMid:5539916  
 
15. Mogensen CE. Microalbuminuria predicts clinical proteinuria 
and early mortality in maturity-onset diabetes. N Engl J Med. 
1984;310:356–60. https://doi.org/10.1056/NEJM198402093100605 
PMid:6690964  
 
16. Saif A, Soliman NA, Abdel-Hameed A. Early evaluation of renal 
hemodynamic alterations in type I diabetes mellitus with duplex 
ultrasound. Saudi J Kidney Dis Transpl. 2010;21:295–99. 
PMid:20228516  
 
17. Pelliccia P, Savino A, Cecamore C, Primavera A, Schiavone C, 
Chiarelli F. Early changes in renal hemodynamics in children with 
diabetes: Doppler sonographic findings. J Clin Ultrasound. 
2008;36(6):335-40. https://doi.org/10.1002/jcu.20457 
PMid:18361467  
 
18. Masolli M., Mancini M., Liuzzi R., Daniele S., Mainenti P.p, 
Vergara E., Genovese S., Salvatore M., Vaccaro O.: Measurement 
of the intrarenal arterial resistance index for the identification and 
prediction of diabetic nephropathy. Nutrition, Metabolism and 
Cardiovascular Diseases. 2009;29 (5): 358–64. 
https://doi.org/10.1016/j.numecd.2008.07.003 PMid:18805683  
 
19. Alter ML, Kretschmer A, Von Websky K, Tsuprykov O, 
Reichetzeder C, et al. Early urinary and plasma biomarkers for 
experimental diabetic nephropathy. Clin Lab. 2012;58:659–71. 
PMid:22997966  
 
 
